Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Medtronic plc (MDT)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
106.87-0.41 (-0.38%)
At close: 04:00PM EST
106.96 +0.09 (+0.08%)
After hours: 07:03PM EST
Advertisement

Medtronic plc

20 On Hatch
Lower Hatch Street
Dublin 2
Ireland
353 1 438 1700
http://www.medtronic.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees90,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Geoffrey Straub MarthaChairman & CEO4.09M776.81k1970
Ms. Karen L. ParkhillExec. VP & CFO3.29MN/A1965
Dr. Richard E. Kuntz M.D., M.Sc.Sr. VP and Chief Medical & Scientific Officer2.61MN/A1957
Mr. Bradley E. LermanSr. VP, Gen. Counsel & Corp. Sec.2.83M2.02M1956
Mr. Robert John WhiteExec. VP & Pres of Medical Surgical Portfolio2.66MN/A1963
Mr. Mark PloofSr. VP of Global Operations and Bus. ServicesN/AN/AN/A
Ms. Jennifer M. KirkPrincipal Accounting Officer, Global Controller & Chief Accounting OfficerN/AN/A1975
Mr. Sean LennonChief Information OfficerN/AN/AN/A
Mr. Ryan WeispfenningVP of Investor RelationsN/AN/AN/A
Ms. Marguerite CopelPR & Interim Chief Communications OfficerN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Medical Surgical Portfolio segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases. The Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Operating Unit segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Corporate Governance

Medtronic plc’s ISS Governance QualityScore as of July 1, 2021 is 6. The pillar scores are Audit: 7; Board: 8; Shareholder Rights: 6; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement